Breaking News

NEW HOPE FOR THALASSAEMIA/SCD | UK Trial Of Lab Grown Red Blood Cells Begins
ADVANCED THERAPIES | Vertex, CRISPR To Submit Exa-Cel to FDA For β-Thalassaemia And Sickle Cell Disease
CDC | Many Children With Sickle Cell Anaemia In The US Not Receiving Lifesaving Screening And Treatment
CLINICAL NEWS | PYRUKYND® Receives Positive CHMP Opinion For The Treatment of PKD in Adults
NEWSLETTER | Iranian Blood Transfusion Organization (IBTO) August 2022
SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System
WORLD PATIENT SAFETY DAY 2022 | Medication Without Harm: Know. Check. Ask.
SICKLE CELL DISEASE | African Health Ministers Launch Drive to Curb SCD’s Toll
A HISTORIC BREAKTHROUGH | UNICEF Signs First-Ever Malaria Vaccine Supply Contract With GSK
BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval

Français

Menu

Accueil
Qui sommes-nous
Notre activité
Les troubles de l’hémoglobine
Prises de Positions et politiques
Publications
Centre des médias
Nous contacter

Rechercher

Accueil/Newsletter/TIF Newsletter – December 2020

TIF Newsletter – December 2020

Moins d’une minute

TIF NEWSLETTER_ December 2020

Moins d’une minute

Facebook X Linkedin Partager par email Imprimer

Articles similaires

TIF Newsletter – October 2020

novembre 12, 2020

TIF Newsletter – August 2020

septembre 18, 2020

TIF Newsletter – May 2020

mai 17, 2020

TIF Newsletter – October 2021

novembre 2, 2021

Voir Aussi

Actualités

BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval
août 17, 2022

Quick links

Per i pazienti
Per gli operatori sanitari
Per le associazioni
Per i sostenitori
Membri della TIF
Link utili
Mappa del sito

TÉLÉCHARGER LES APPLICATIONS

Appli ThaliMe

ABONNEZ-VOUS À NOTRE BULLETIN D’INFORMATION

© Copyright 2024, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Facebook X WhatsApp

Bouton retour en haut de la page

Fermer

Facebook
X
Linkedin
YouTube
Instagram
RSS

Rechercher :